Routine Vaccination Schedule

Diphtheria, tetanus, pertussis

Polio

Rotavirus gastroenteritis

Haemophilus influenzae type B

Meningococcal group B

Hepatitis B

Diphtheria, tetanus, pertussis

Polio

Rotavirus gastroenteritis

Haemophilus influenzae type B

Hepatitis B

Pneumococcal (13 serotypes)

Diphtheria, tetanus, pertussis

Polio

Haemophilus influenzae type B

Meningococcal group B

Hepatitis B

Measles, mumps, and rubella (MMR)

Haemophilus influenzae type B

Meningococcal group B

Booster dose

Meningococcal group C

Pneumococcal (13 serotypes)

Influenza

Each year from September. If live attenuated influenza vaccine (LAIV) is contraindicated or otherwise unsuitable, use inactivated influenza vaccine (IIV)

Diphtheria, tetanus, pertussis

Polio

Measles, mumps, and rubella (MMR)

Check first dose given

Human papillomavirus (HPV)

From September 2023, offer a one-dose schedule for the routine adolescent programme

Tetanus, diphtheria

Check MMR status

Polio

Check MMR status

Meningococcal groups A, C, W, and Y

Herpes zoster (shingles)

Pneumococcal (23 serotypes)

Covid-19

All adults aged 65 years and over are eligible for the Autumn 2024 COVID-19 booster vaccination, as well as certain other groups ^[E]

Influenza

Each year from September. Certain other groups are also eligible^[F]

Herpes zoster (shingles)

Respiratory syncytial virus (RSV)

From 1 September 2024. Eligibility in current cohort ends at age 80 years

Hepatitis B

Babies born to hepatitis B infected mothers. In addition, hexavalent vaccine (Infanrix hexa or Vaxelis) is given at 8, 12, and 16 weeks.

Tuberculosis (TB)

Infants in areas of the country with TB incidence ≥ 40/100,000 or with a parent or grandparent born in a high incidence country

Hepatitis B

Babies born to hepatitis B infected mothers. In addition, hexavalent vaccine (Infanrix hexa or Vaxelis) is given at 8, 12, and 16 weeks.

Hepatitis B

Babies born to hepatitis B infected mothers. In addition, hexavalent vaccine (Infanrix hexa or Vaxelis) is given at 8, 12, and 16 weeks. Take blood for HBsAg at 12 months to exclude infection.

Influenza

At-risk children: live attenuated influenza vaccine (LAIV), or inactivated influenza vaccine (IIV) if LAIV contraindicated or child is under 2 years of age

COVID-19

Eligibility includes some eligible children and young adults, and pregnant women. Eligibility criteria can be found in the Green Book, chapter 14a

Pertussis (whooping cough)

Pregnant women from 16 weeks of gestation

Influenza

Pregnant women during flu season, at any stage of pregnancy

Respiratory syncytial virus (RSV)

From 1 September 2024. From 28 weeks’ gestation, either opportunistically or on request

Human papillomavirus (HPV)

A one-dose schedule for eligible gay, bisexual, and other men who have sex with men (GBMSM) <25 years of age. A two-dose schedule for eligible GBMSM individuals from the age of 25 years (0, 6–24 months)

COVID-19

Eligibility includes some eligible children and young adults, and pregnant women. Eligibility criteria can be found in the Green Book, chapter 14a

Human papillomavirus (HPV)

A three-dose schedule for eligible individuals who are immunosuppressed and those known to be living with HIV, including those on antiretroviral therapy (0, 1, 4–6-month schedule)

Influenza

Each year from September. If live attenuated influenza vaccine (LAIV) is contraindicated or otherwise unsuitable in children, use inactivated influenza vaccine (IIV)

Pneumococcal

Influenza

Each year from September for those with asplenia or splenic dysfunction, chronic respiratory/heart/neurological/liver conditions, diabetes, chronic kidney disease, complement disorders. If live attenuated influenza vaccine (LAIV) is contraindicated or otherwise unsuitable in children, use inactivated influenza vaccine (IIV)

Pneumococcal

For asplenia or splenic dysfunction, cochlear implants, chronic respiratory/heart/neurological/liver conditions, diabetes, chronic kidney disease, complement disorders